Prelude Capital Management’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,661
| Closed | -$1.23M | – | 1388 |
|
|
2026
Q1 | $1.23M | Buy |
2,661
+1,142
| +75% | +$578K | 0.09% | 254 |
|
|
2025
Q4 | $860K | Sell |
1,519
-267
| -15% | -$142K | 0.06% | 357 |
|
|
2025
Q3 | $799K | Buy |
1,786
+128
| +8% | +$61.4K | 0.06% | 366 |
|
|
2025
Q2 | $901K | Sell |
1,658
-208
| -11% | -$109K | 0.09% | 285 |
|
|
2025
Q1 | $924K | Buy |
1,866
+236
| +14% | +$131K | 0.07% | 328 |
|
|
2024
Q4 | $851K | Buy |
1,630
+90
| +6% | +$46.9K | 0.05% | 435 |
|
|
2024
Q3 | $757K | Buy |
1,540
+90
| +6% | +$41.9K | 0.05% | 468 |
|
|
2024
Q2 | $645K | Sell |
1,450
-1,220
| -46% | -$486K | 0.04% | 436 |
|
|
2024
Q1 | $1.07M | Buy |
2,670
+711
| +36% | +$269K | 0.06% | 383 |
|
|
2023
Q4 | $661K | Sell |
1,959
-2,629
| -57% | -$784K | 0.04% | 413 |
|
|
2023
Q3 | $1.34M | Buy |
4,588
+1,331
| +41% | +$416K | 0.09% | 256 |
|
|
2023
Q2 | $1.11M | Buy |
3,257
+1,763
| +118% | +$533K | 0.07% | 288 |
|
|
2023
Q1 | $382K | Sell |
1,494
-2,809
| -65% | -$692K | 0.02% | 557 |
|
|
2022
Q4 | $1.14M | Buy |
+4,303
| New | +$1.05M | 0.06% | 340 |
|
|
2022
Q2 | – | Sell |
-6,595
| Closed | -$1.55M | – | 1929 |
|
|
2022
Q1 | $1.99M | Buy |
6,595
+3,424
| +108% | +$1M | 0.06% | 340 |
|
|
2021
Q4 | $1.14M | Buy |
3,171
+993
| +46% | +$342K | 0.03% | 545 |
|
|
2021
Q3 | $722K | Sell |
2,178
-1,593
| -42% | -$535K | 0.02% | 711 |
|
|
2021
Q2 | $1.16M | Buy |
3,771
+90
| +2% | +$25.2K | 0.03% | 538 |
|
|
2021
Q1 | $907K | Buy |
3,681
+2,592
| +238% | +$652K | 0.02% | 638 |
|
|
2020
Q4 | $297K | Sell |
1,089
-495
| -31% | -$123K | 0.01% | 918 |
|
|
2020
Q3 | $375K | Buy |
1,584
+1,443
| +1,023% | +$324K | 0.02% | 501 |
|
|
2020
Q2 | $27K | Sell |
141
-540
| -79% | -$96.8K | ﹤0.01% | 1321 |
|
|
2020
Q1 | $112K | Sell |
681
-1,134
| -62% | -$208K | 0.01% | 565 |
|
|
2019
Q4 | $358K | Buy |
+1,815
| New | +$340K | 0.01% | 666 |
|
|
2018
Q3 | – | Sell |
-4,380
| Closed | -$699K | – | 1873 |
|
|
2018
Q2 | $699K | Buy |
4,380
+4,233
| +2,880% | +$646K | 0.04% | 426 |
|
|
2018
Q1 | $20K | Buy |
+147
| New | +$20.5K | ﹤0.01% | 1265 |
|
|
2017
Q1 | – | Sell |
-1,386
| Closed | -$98K | – | 1618 |
|
|
2016
Q4 | $98K | Sell |
1,386
-1,395
| -50% | -$103K | 0.01% | 844 |
|
|
2016
Q3 | $224K | Buy |
2,781
+1,269
| +84% | +$97.2K | 0.02% | 535 |
|
|
2016
Q2 | $111K | Sell |
1,512
-2,052
| -58% | -$144K | 0.02% | 716 |
|
|
2016
Q1 | $238K | Buy |
+3,564
| New | +$221K | 0.03% | 495 |
|
|
2015
Q1 | – | Sell |
-1,800
| Closed | -$106K | – | 2039 |
|
|
2014
Q4 | $106K | Sell |
1,800
-2,250
| -56% | -$125K | 0.02% | 979 |
|
|
2014
Q3 | $208K | Buy |
4,050
+3,150
| +350% | +$156K | 0.03% | 700 |
|
|
2014
Q2 | $41K | Buy |
+900
| New | +$39.7K | 0.01% | 1449 |
|
|
2014
Q1 | – | Sell |
-1,791
| Closed | -$84.4K | – | 1993 |
|
|
2013
Q4 | $76K | Hold |
1,791
| – | – | 0.01% | 962 |
|
|
2013
Q3 | $75K | Buy |
+1,791
| New | +$79.1K | 0.01% | 864 |
|
Other funds holding ISRG
Prelude Capital Management's ISRG Position: Q2 2026 in Review
Prelude Capital Management sold out of Intuitive Surgical (ISRG) in Q2 2026, closing a stake of 2,661 shares — an estimated $1.23M sold.
Prelude Capital Management first reported a position in ISRG in Q3 2013 and held it in 35 quarters. The position peaked at $1.99M in Q1 2022. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Prelude Capital Management reported no remaining Intuitive Surgical position as of Q2 2026 after selling out during the quarter.
- Prelude Capital Management sold 2,661 Intuitive Surgical shares in Q2 2026, an estimated $1.23M.
- Prelude Capital Management first reported a position in Intuitive Surgical in Q3 2013 and held it in 35 quarters.
- Prelude Capital Management's Intuitive Surgical position peaked at $1.99M in Q1 2022.
- 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.